Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome injection for post-hemorrhoidectomy analgesia
ChiCTR2500098731Phase 4Completed
- Sponsor
- The Third Affiliated Hospital of Henan University of Traditional Chinese Medicine
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in hemorrhoid (2 arms), sponsored by The Third Affiliated Hospital of Henan University of Traditional Chinese Medicine. Primary endpoints: Pain score (visual analogue scale), Edema score and 2 more. Started Mar 2025; status: completed.
02
Drugs
bupivacaine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ChiCTR2500098731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098731.